首页> 外文期刊>Nature clinical practice. Oncology >Serrated adenoma of the colorectum and the DNA-methylator phenotype.
【24h】

Serrated adenoma of the colorectum and the DNA-methylator phenotype.

机译:大肠的锯齿状腺瘤和DNA-甲基化子表型。

获取原文
获取原文并翻译 | 示例
       

摘要

Serrated adenomas (SA) of the colorectum show features intermediate between hyperplastic polyps (HP) and adenomas. HP and SA are related lesions and there is now strong evidence for a 'serrated-polyp pathway' to colorectal cancer (CRC) that is largely independent of the classic adenoma-to-carcinoma sequence. A recently recognized lesion in this pathway is a HP variant characterized by relatively large size, atypical histology and proximal location in the colorectum. This HP variant has been given a variety of names in the literature including 'sessile SA' and 'type I SA'. Because this lesion lacks the traditional cytology of colorectal adenoma and in order to avoid confusion with SA, it is referred to in this review as sessile serrated polyp. SA are characterized by a heterogeneous group of changes at the molecular level, but a high proportion have BRAFmutations and DNA methylation. They may develop in HP or sessile serrated polyps, or may arise de novo. In the serratedpolyp pathway, the advent of genetic instability is likely to be an important rate-limiting step that drives rapid neoplastic evolution. Methylation and inactivation of the DNA repair genes MLH1 and MGMT (O-6-methylguanine-DNA methyltransferase) have been proposed as critical steps leading to genetic instability. Stretches of DNA rich in the bases guanine and cytosine (CpG islands; where p represents a phosphodiester bond linking adjacent cytosine and guanine bases) that are normally unmethylated may become methylated in malignant human colorectal tumors. Subsets of colorectal cancers with an unusually high number of methylated CpG islands have been described as having the 'CpG-island-methylator phenotype' It is possible that many, if not all, CRCs with the CpG-island-methylator phenotype evolve through the serrated-polyp pathway that would, therefore, explain approximately 20% of all CRCs. The current lack of guidelines for managing serrated polyps may explain the static incidence of proximal CRC, despite the falling incidence rates for left-sided CRC during the same time period.
机译:大肠的锯齿状腺瘤(SA)显示介于增生性息肉(HP)和腺瘤之间的特征。 HP和SA是相关的病变,现在有强有力的证据表明大肠癌(CRC)的“锯齿状息肉途径”在很大程度上不依赖于经典的腺瘤-癌序列。该途径中最近发现的病变是HP变体,其特征是相对较大的大小,非典型的组织学和在结直肠中的近端位置。该HP变体在文献中已被赋予多种名称,包括“无柄SA”和“ I型SA”。由于该病变缺乏大肠腺瘤的传统细胞学检查,并且为了避免与SA混淆,在本综述中将其称为无柄锯齿状息肉。 SA的特点是在分子水平上具有异质性变化,但很大一部分具有BRAF突变和DNA甲基化。它们可能在HP或无柄锯齿状息肉中发展,或从头出现。在锯齿状息肉途径中,遗传不稳定性的出现可能是驱动肿瘤快速发展的重要限速步骤。 DNA修复基因MLH1和MGMT(O-6-甲基鸟嘌呤-DNA甲基转移酶)的甲基化和失活已被认为是导致遗传不稳定的关键步骤。正常情况下未甲基化的富含鸟嘌呤和胞嘧啶碱基(CpG岛;其中p代表连接相邻胞嘧啶和鸟嘌呤碱基的磷酸二酯键)的DNA片段可能在恶性人类大肠直肠肿瘤中被甲基化。甲基化CpG岛数量异常高的结直肠癌亚群已被描述为具有“ CpG-岛-甲基化子表型”。许多(如果不是全部)具有CpG-岛-甲基化子表型的CRC可能通过锯齿状演化。 -息肉途径,因此可以解释所有CRC的约20%。尽管在同一时间段内左侧CRC的发生率下降,但目前缺乏用于处理锯齿状息肉的指南可能可以解释近端CRC的静态发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号